What is the ROCE (Return on Capital Employed) of CardieX this year?
The ROCE of CardieX is -1.49 undefined this year.
CardieX ROCE 2024
CardieX ROCE
-1.49
Ticker
CDX.AX
ISIN
AU0000015729
WKN
A2JN9Z
In 2024, CardieX's return on capital employed (ROCE) was -1.49, a -14.83% increase from the -1.76 ROCE in the previous year.
CardieX Aktienanalyse
What does CardieX do?
Cardiex Ltd is an Australian medical technology company specializing in the development and marketing of cardiovascular monitoring systems and diagnostic tools. The company was founded in 1996 and is based in Melbourne. Cardiex's history begins with the development of SphygmoCor technology in collaboration with researchers from Monash University. This technology allows for non-invasive measurement of pulse and blood pressure waves in the arteries, providing information about the condition of the cardiovascular system. Cardiex's first product was the SphygmoCor Analyzer, which was launched in 1999. Over time, additional products and technologies have been developed to meet the growing demand for cardiovascular monitoring and diagnostics. Cardiex's business model is based on the development and marketing of innovative medical technologies for the international market. The company works closely with clinics, research institutions, and medical device manufacturers to develop products that meet the needs of the healthcare sector. Cardiex has a comprehensive network of sales and marketing partners in over 40 countries worldwide. Cardiex operates in several divisions, including: - Diagnostic Systems: This division includes products such as the SphygmoCor Analyzer, which assesses arterial health, and the Arterial Stiffness Scanner, which enables early detection of cardiovascular risk factors. - Telemedicine: Cardiex offers a telehealth platform that allows clinics and medical personnel to monitor and analyze patient data in real-time. The platform can be used for remote patient monitoring, early detection of complications, and treatment optimization. - Research and Development: Cardiex collaborates closely with researchers and medical institutions to develop new technologies for cardiovascular monitoring and diagnostics. The company invests heavily in research and development to maintain a leading role in the field of medical technology. An important aspect of Cardiex's business model is its partnership with other companies. The company works closely with device manufacturers, software developers, and other service providers to integrate its technologies and products, offering complete solutions for the healthcare sector. Cardiex's products include not only the SphygmoCor Analyzer but also the Arterial Stiffness Scanner, Ambulatory Blood Pressure Monitor, CardiexCare data management system, and telehealth platform. All these products are designed to simplify and improve the monitoring and diagnosis of cardiovascular diseases. Overall, Cardiex is a successful medical technology company specializing in the development and marketing of innovative cardiovascular monitoring systems and diagnostic tools. The company has expanded its product and service offerings in recent years and has a strong international presence. Through close collaboration with other companies and research institutions, Cardiex will continue to play a leading role in the field of medical technology in the future. CardieX ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling CardieX's Return on Capital Employed (ROCE)
CardieX's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing CardieX's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
CardieX's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in CardieX’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about CardieX stock
How has the ROCE (Return on Capital Employed) of CardieX developed compared to the previous year?
The ROCE of CardieX has increased by -14.83% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of CardieX?
A high Return on Capital Employed (ROCE) indicates that CardieX has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of CardieX?
A low ROCE (Return on Capital Employed) can indicate that CardieX has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from CardieX impact the company?
An increase in the ROCE of CardieX can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of CardieX affect the company?
A decrease in ROCE of CardieX can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of CardieX?
Some factors that can affect CardieX's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of CardieX so important for investors?
The ROCE of CardieX is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can CardieX take to improve the ROCE?
To improve the ROCE, CardieX can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does CardieX pay?
Over the past 12 months, CardieX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CardieX is expected to pay a dividend of 0 AUD.
What is the dividend yield of CardieX?
The current dividend yield of CardieX is .
When does CardieX pay dividends?
CardieX pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of CardieX?
CardieX paid dividends every year for the past 0 years.
What is the dividend of CardieX?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is CardieX located?
CardieX is assigned to the 'Health' sector.
Wann musste ich die Aktien von CardieX kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CardieX from 11/8/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.
When did CardieX pay the last dividend?
The last dividend was paid out on 11/8/2024.
What was the dividend of CardieX in the year 2023?
In the year 2023, CardieX distributed 0 AUD as dividends.
In which currency does CardieX pay out the dividend?
The dividends of CardieX are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von CardieX
Our stock analysis for CardieX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CardieX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
